See the following AlzForum article, including comments at the bottom from independent researchers.
Finally: Big Win on All Outcomes for Lecanemab in Phase 3 Topline Results:
Another good-news story - this time for A... - Cure Parkinson's
Another good-news story - this time for Alzheimer's disease - Lecanemab (an anti-amyloid antibody) achieves some success in a Phase 3 trial
Written by
jeffreyn
To view profiles and participate in discussions please or .
1 Reply
•
Yes, the big question for us is does this mean the amyloid theory bears weight? (So would removing the Alpha synuclein for PD have therpudic benefits also). Maybe there's hope!
Not what you're looking for?
You may also like...
Buntanetape updates
a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases...
ANNOVIS BIO ANNOUNCES POSITIVE FDA NOTICE FOR BUNTANETAP PHASE 3 CLINICAL TRIAL IN PARKINSON'S DISEASE
https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?airportNewsID=e4e0b40
Inosine, Israpidine, NAC, Glutathione clinical trials - Love to hear from those who have experience with these.
Inosine and NAC trials are still open.
Glutathione trial complete (I would like to see the......
Update on Affiris Vaccine - Phase 1 results
https://www.news-medical.net/news/20200618/AFFiRiS-AG-announces-results-of-phase-1-trial-with-PD01A-
BioVie announces treatment of 1st patient in Phase 2 clinical trial of NE3107,ERK inhibitor that selectively inhibits neuroinflammation
BioVie announces treatment of 1st patient in Phase 2 clinical trial of NE3107 (an ERK inhibitor...
Related Posts
Ambroxol Phase 2 results 
Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease
Hot off the press. Randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease.
Medicinal cannabis improves outcomes in Parkinson's patients- Ambroxol in Parkinson's: Results of Phase ll Trial Published
